Brand Index Methodology
The Morning Consult Brand Index is an indicator of brand strength among consumers. Each Fortune 500 company receives a score based on a ratio of favorable to unfavorable impressions among U.S. adults and its overall favorability. This ensures that a score takes into account how well-liked a company is among people who have an opinion of it without penalizing companies that are not consumer-facing.
Morning Consult polls thousands of adults across the country each week. The surveys are conducted online using large, established online survey vendors. The data is weighted to approximate a nationally representative sample based on age, race/ethnicity, gender, educational attainment, region, annual household income, home ownership status and marital status.
The Pennsylvania-based drug distributor saw revenues grow in 2017 thanks to increased business from some of its largest customers and strong sales of expensive cancer drugs. Amerisources’s animal health unit, MWI, also recorded strong sales growth thanks to its brisk pet medicine business. Profits took a hit due to accrued litigation costs from the previous year. Like other large drug distributors, Amerisource faces a number of lawsuits over its alleged role in the nation’s opioid epidemic.
CEO
Steven H. Collis
CEO Title
Chairman, President & Chief Executive Officer
Sector
Wholesalers
Industry
Wholesalers: Health Care
HQ Location
Chesterbrook, Pa.
Website
Years on Fortune 500 List
24
Employees
19,500
SPONSOR CENTER
| $ millions | % change | |
|---|---|---|
| Revenues ($M) | $153,144 | 4.3% |
| Profits ($M) | $364.5 | -74.5% |
| Assets ($M) | $35,317 | |
| Total Stockholder Equity ($M) | $2,065 | |
| Market Value — as of March 29, 2018 ($M) | $18,938 |
| Profit as % of Revenues | 0.2% | |
| Profits as % of Assets | 1.0% | |
| Profits as % of Stockholder Equity | 17.7% |
| Earnings Per Share ($) | 1.64 | |
| EPS % Change (from 2016) | -74.1% | |
| EPS % Change (5 year annual rate) | -10.1% | |
| EPS % Change (10 year annual rate) | 2.8% |
| Total Return to Investors (2017) | 19.4% | |
| Total Return to Investors (5 year, annualized) | 18.0% | |
| Total Return to Investors (10 year, annualized) | 16.6% |
- Previous Close:
- Market Cap: NaNB
- Next Earnings Date:
- High:
- Low:
- 52 Week High:
- 52 Week Low:
- 52 Week Change %: 0.00
- P/E Ratio: n/a
- EPS:
- Dividend Yield: n/a
News about AmerisourceBergen
Bold acquisitions and global expansion lifted Amerisource's ranking to number 12 on Fortune 500
Steve Collis predicts new era of where drug prices are going to come down.
Amazon and CVS are putting on the pressure.
Sparking a selloff in the shares of a host of health care-related companies.
Corporate governance matters, too.
Quotes delayed at least 15 minutes. Market data provided by Interactive Data. ETF and Mutual Fund data provided by Morningstar, Inc.. Dow Jones Terms & Conditions: http://www.djindexes.com/mdsidx/html/tandc/indexestandcs.html. S&P Index data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions